The problem is, Bedrocan charges $5 plus tax for their product if I were to switch, when Tweed sells $6 strains they can be bought at $4.80 plus tax if you qualify for compassionate pricing.
To some people, the 20 cent difference may not matter, but I don't know Bedrocan product, my wife hasn't tried it and we don't want to either. We like the Tweed brand, we like it's product. We are really just big fans of the company, what it is doing and how it is doing it.
I may have bought a bunch of Bedrocan shares at one time, but only because Bruce Linton said he was going to buy it for more than their current price was at the time due to the relative prices of the two stocks and the exchange ratio - but I would rather just stick with Tweed if I can.
But you will see, Bruce Linton is already catching on - he said in the last interview that he underestimated price sensitivity - the game is going to be about producing good buds, good brand, always available, good price
you give that to people they will never leave. But today, right now someone is waking up and thinking about ordering new product, and they are disappointed with the available selection - in two days I will be one of them. They are getting feedback on it right now I am sure, someone at customer support is dealing with a patient that wants meds that were available 3 days ago, in two days I will want to order 120 grams of cannabis. It takes days, emails and faxes to switch LP's and we don't want to, so I hope they have some product that will satisfy my demand.
I really don't care if Bruce thinks this is a 'rec' brand, he was given a license to produce medicine, when he gets a license to produce cannabis meant only for pleasure purposes then things may be different, but he should keep the medicine on the shelves first
News 
Market Data 
Discover 
